000 | 04289cam a2200445 i 4500 | ||
---|---|---|---|
001 | on1286956202 | ||
003 | OCoLC | ||
005 | 20240726104517.0 | ||
008 | 211202s2022 sz a ob 000 0 eng d | ||
020 | _a3030867056 | ||
020 | _a9783030867058 | ||
029 | 1 |
_aAU@ _b000070299271 |
|
029 | 1 |
_aAU@ _b000070419128 |
|
040 |
_aYDX _beng _erda _epn _cYDX _dGW5XE _dEBLCP _dOCLCF _dOCLCO _dDKU _dNT _dOCLCQ _dOCLCO |
||
049 | _aSBIM | ||
050 | 0 | 4 |
_aRA644 _b.F438 2022 |
100 | 1 |
_aCascella, Marco, _e1 |
|
245 | 1 | 0 | _aFeatures and management of acute and chronic neuro-Covid /Marco Cascella, Elvio De Blasio. |
260 |
_aCham : _bSpringer, _c(c)2022. |
||
300 |
_a158 pages : _billustrations, charts : _c24 cm |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_adata file _2rda |
||
504 | _a1 | ||
505 | 0 | 0 | _aPart I. Pathophysiology of COVID-19-associated neurotoxicity |
505 | 0 | 0 |
_aAn update on preclinical findings -- _tOngoing clinical investigations -- _tPerspectives |
505 | 0 | 0 | _aPart II. Clinical manifestations of acute neurotoxicity |
505 | 0 | 0 |
_aClinical features -- _tCNS complications -- _tPNS complications -- _tDiagnosis.-Management -- _tPerspectives |
505 | 0 | 0 | _aPart III. Neurological and psychiatric sequelae in COVID-19 survivors: Clinical features |
505 | 0 | 0 |
_aNeurological late complications -- _tpsychological and psychiatric sequelae.-Diagnosis -- _tTools -- _tThe role of imaging -- _tPreventive strategies -- _tSocial and economic impact.-Multidisciplinary management -- _tPerspectives |
520 | 0 | _aThis book underlines how COVID-19 is a multisystem inflammatory disease and how its pathophysiology can predispose to an increased risk of neurological issues. Several scientific pieces of evidence showes the mechanisms underlying the neuroinvasive capacity of the SARS-CoV-2 through direct viral damage and indirect processes entering the CNS by different routes including the vasculature, the olfactory and trigeminal nerves, the cerebrospinal fluid, and the lymphatic system inducing a direct neurotoxicity. Furthermore, the pro-inflammatory cytokine storm and oxidative stress can induce microglial activation and damage to the blood-brain barrier, culminating in widespread neuroinflammatory process. This acute neurotoxicity is clinically expressed as anosmia and ageusia, headache, nausea and vomiting, but other neurologic manifestations such as acute cerebrovascular diseases, consciousness impairment due to encephalitis, and meningitis are also described. The PNS can also be affected by infectious damage and clinical manifestations including Guillain-Barr e syndrome, polyneuritis cranialis, and Miller Fisher Syndrome. A special issue concerns the neurocognitive dysfunction and altered consciousness manifested as delirium, agitation and confusion. Non-specific symptoms such as dizziness, seizures can accompany clinical pictures. Regardless of the admission diagnosis, a high percentage of patients discharged from ICUs develop disabilities affecting physical, cognitive and psychological activities. The symptoms such as asthenia, memory disturbances, depression, sleep disturbances, anxiety, and Post-traumatic stress disorder (PTSD), configure the so-called Post-intensive Care Syndrome (PICS). Multimodal management during the ICU stay and implementation of follow-up programs at patient discharge can reduce the incidence of this syndrome, improving the quality of life of surviving patients. In this complex scenario, a careful clinical approach through reliable diagnostic tools, and epidemiological studies aimed at evaluating the dimensions of the problem also in economic terms, is urgently needed. This book represents a valuable aid for all those healthcare professionals (intensivists, neurologist and psychiatrists, as well) involved in the management of these critically ill patients. | |
530 |
_a2 _ub |
||
650 | 0 |
_aCOVID-19 (Disease) _xPathophysiology. |
|
650 | 0 | _aNeurologic manifestations of general diseases. | |
650 | 0 | _aNeurologic Manifestations. | |
655 | 4 | _aMEDICAL. | |
700 | 1 |
_aDe Blasio, Elvio, _e1 |
|
942 |
_cNUR _eAMAZON _hRA _i2021-2022 _k129.59 _m2022 _nNURS _O112-6793931-0707467 _RNURSING DEPARTMENT _2lcc |
||
999 |
_c69159 _d69159 |
||
902 |
_a1 _bCynthia Snell _c1 _dCynthia Snell |